Herpetic Whitlow Under the Microscope: Landmark Review Maps Decades of Published Cases

Herpetic whitlow, the painful blistering infection of the fingers caused by herpes simplex virus, has long been described as a classic condition that clinicians nevertheless frequently misdiagnose. A new research letter published in the Archives of Dermatological Research brings renewed attention to this underappreciated disease by systematically reviewing previously published case reports, drawing together fragmented clinical observations that have accumulated in the medical literature for more than sixty years. The review, led by Nina Vijayvargiya of Weill Cornell Medical College together with Amit Singal of Rutgers New Jersey Medical School, Maggie H. Zhou of Columbia University Vagelos College of Physicians and Surgeons, and senior author Shari R. Lipner of the Department of Dermatology at Weill Cornell Medicine, represents one of the most comprehensive consolidations of case-level evidence on the condition and offers clinicians a clearer picture of how whitlow presents, whom it strikes, and how it should be managed.

Herpetic whitlow results when herpes simplex virus, most commonly herpes simplex virus type 1, inoculates the skin of a digit through a break in the cutaneous barrier. The virus travels to sensory nerve endings, establishes infection in the distal phalanx, and produces one or more intensely painful vesicles that may coalesce into a larger blister resembling a bacterial felon or paronychia. The infection classically affects the thumb and index finger, though any digit may be involved. In children, autoinoculation from thumb-sucking or finger-sucking during oral herpetic infections is the dominant route of acquisition, while in adults the disease has historically been an occupational hazard among dentists, dental hygienists, and other health care workers exposed to oral secretions before the widespread adoption of gloves.

The historical record captured in the review begins with early observations that established whitlow as a nosocomial threat. Among the foundational works cited is a 1959 Lancet study by Stern and colleagues describing herpetic whitlow as a form of cross-infection in hospitals, a report that helped define the condition’s public health significance at a time when its viral etiology was still being separated from pyogenic infections of the hand. By the end of the twentieth century, larger clinical series such as the 1990 analysis by Gill and colleagues of herpes simplex virus infection of the hand, published in the Journal of the American Academy of Dermatology, had clarified the spectrum of disease in adults and children alike, documenting incubation periods, recurrence patterns, and the substantial morbidity that recurrent infection imposes on patients.

The technical groundwork for the present synthesis rests on several strands of evidence. Case reports of pediatric whitlow, exemplified by the 2001 European Journal of Pediatrics report by Szinnai and colleagues describing multiple herpetic whitlow lesions in a four-year-old girl, illustrate how extensive the lesions can become in young children and how easily the presentation can be mistaken for more common blistering disorders. Occupational case series, including the 2012 report by Browning and McCarthy in the Journal of Esthetic and Restorative Dentistry documenting herpes simplex virus as an occupational hazard among dental practitioners, reinforce the role of exposure routes in shaping who develops the disease. On the therapeutic side, the pharmacological understanding of nucleoside analogs such as acyclovir and its relatives has matured considerably, as summarized in the 2022 PharmGKB review by Maillard and colleagues of the acyclovir and ganciclovir metabolic pathway, which maps how these prodrugs are converted by viral and cellular thymidine kinases into active triphosphate forms that selectively inhibit viral DNA polymerase.

By pooling published case material, the Weill Cornell-led team sought to define the epidemiological and clinical profile of herpetic whitlow with more precision than any single case report could provide. The review’s design reflects a growing appreciation in dermatology that rare or underrecognized conditions accumulate meaningful evidence only when scattered reports are aggregated and analyzed together. The researchers coordinated the project across four institutions, with Vijayvargiya responsible for data collection, Vijayvargiya and Zhou performing the analysis and drafting, Singal contributing to conception, design, and revision, and Lipner overseeing the work and providing final approval. The authors declared no competing interests and reported no external funding for the study, and the paper was accepted on 1 September 2026 and published on 12 September 2026 in volume 318 of the journal.

The clinical importance of distinguishing herpetic whitlow from bacterial infections of the hand cannot be overstated. Misdiagnosis as a bacterial felon or paronychia has historically led to incision and drainage, a surgical intervention that is not only unnecessary for viral infection but potentially harmful, because breaching the skin can introduce secondary bacterial infection or delay appropriate antiviral therapy. Recognizing the characteristic morphology of whitlow, grouped vesicles on an erythematous base with a predilection for the distal phalanx, along with a history of prior oral or genital herpes lesions, exposure to oral secretions, or recent trauma to the digit, allows clinicians to avoid inappropriate surgery and initiate antiviral treatment promptly. Diagnostic confirmation, when needed, can be achieved through viral culture, polymerase chain reaction testing, or Tzanck smear, though the classic presentation in most cases permits clinical diagnosis.

Therapy for herpetic whitlow rests on antiviral agents, principally acyclovir, valacyclovir, and famciclovir, which shorten the duration of viral shedding and accelerate healing when initiated early in the course of infection. The pharmacogenetic pathway described by Maillard and colleagues explains both the selectivity and the limitations of these drugs: acyclovir is preferentially phosphorylated by virus-encoded thymidine kinase, concentrating active drug in infected cells, but resistance can emerge in immunocompromised patients through loss or alteration of the viral kinase, in which case drugs with alternative mechanisms, such as foscarnet, may be required. For immunocompetent patients, most episodes resolve spontaneously within two to four weeks, though recurrent disease can be frequent, painful, and disruptive, particularly for health care workers whose livelihoods depend on unimpaired hand function.

Prevention strategies highlighted across the reviewed literature emphasize simple but effective measures. The dramatic decline in occupational whitlow among dental professionals after routine gloving became standard practice stands as one of the clearest demonstrations that barrier precautions control transmission of herpes simplex virus in clinical settings. In households, parents and caregivers with active oral herpes lesions can reduce transmission to children by avoiding kissing children on or near the mouth, not sharing utensils and towels, and discouraging thumb-sucking in children with active herpetic gingivostomatitis. People with recurrent whitlow can reduce autoinoculation risk by avoiding contact between their lesions and other body sites, particularly the eyes, where herpes infection can threaten vision.

The consolidated picture that emerges from this review serves a dual purpose. For clinicians, it provides an evidence-based reference point for recognizing a condition that, despite its distinctive appearance, continues to be misdiagnosed in emergency departments, pediatric clinics, and dermatology practices. For researchers, it identifies gaps in the literature, including the relative scarcity of prospective studies and randomized treatment trials in both children and adults, since most of the evidence base remains built on individual case reports and small series. As antiviral pharmacology advances and awareness of occupational and household transmission routes deepens, syntheses of the kind now published by the Weill Cornell, Rutgers, and Columbia collaboration help ensure that the accumulated clinical wisdom of six decades of case reporting is not lost but translated into better diagnosis, more judicious treatment, and fewer preventable infections of the hand.

Subject of Research: Herpetic whitlow: a systematic review of published herpes simplex virus infection cases of the fingers

Article Title: Review of published herpetic whitlow cases

Article References: Vijayvargiya, N., Singal, A., Zhou, M. H., & Lipner, S. R. (2026). Review of published herpetic whitlow cases. Archives of Dermatological Research, 318(1), Article 412. https://doi.org/10.1007/s00403-026-04923-x

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04923-x

Keywords: herpetic whitlow, herpes simplex virus, dermatology, acyclovir, occupational infection, pediatric herpes, antiviral therapy, nail and hand infection, case report review, viral infection, dental health workers, autoinoculation